Consolidated and Combined Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Total revenues	$ 19,672	$ 19,552	$ 18,341
Gross profit	8,205	7,922	7,179
Selling, general, and administrative	4,269	4,282	3,631
Research and development	1,311	1,205	1,026
Total operating expenses	5,580	5,487	4,657
Operating income	2,625	2,435	2,522
Interest and other financial charges – net	504	542	77
Non-operating benefit (income) costs	(406)	(382)	(5)
Other (income) expense – net	(55)	(86)	(62)
Income from continuing operations before income taxes	2,581	2,361	2,512
Benefit (provision) for income taxes	(531)	(743)	(563)
Net income from continuing operations	2,050	1,618	1,949
Income (loss) from discontinued operations, net of taxes	0	(4)	18
Net income	2,050	1,614	1,967
Net (income) loss attributable to noncontrolling interests	(57)	(46)	(51)
Net income attributable to GE HealthCare	1,993	1,568	1,916
Deemed preferred stock dividend of redeemable noncontrolling interest	0	(183)	0
Net income attributable to GE HealthCare common stockholders	$ 1,993	$ 1,385	$ 1,916
Earnings per share from continuing operations attributable to GE HealthCare common stockholders:
Basic (in dollars per share)	$ 4.37	$ 3.06	$ 4.18
Diluted (in dollars per share)	4.34	3.04	4.18
Earnings per share attributable to GE HealthCare common stockholders:
Basic (in dollars per share)	4.37	3.05	4.22
Diluted (in dollars per share)	$ 4.34	$ 3.03	$ 4.22
Weighted-average number of shares outstanding:
Basic (in shares)	456	455	454
Diluted (in shares)	459	458	454
Product
Total revenues	$ 13,075	$ 13,127	$ 12,044
Cost of sales	8,271	8,465	7,975
Service
Total revenues	6,597	6,425	6,297
Cost of sales	$ 3,196	$ 3,165	$ 3,187